(Q35895018)

11 August 2017

Cost-effectiveness of chronic kidney disease mass screening test in Japan (English)

1 reference

chronic renal insufficiency

11 August 2017

1 reference

1 reference

2

Kunihiro Yamagata

1 reference

11 August 2017

9

Kunitoshi Iseki

1 reference

11 August 2017

Masahide Kondo

1

1 reference

11 August 2017

Shu-ling Hoshi

3

1 reference

11 August 2017

Chie Saito

4

1 reference

11 August 2017

Koichi Asahi

5

1 reference

11 August 2017

Toshiki Moriyama

6

1 reference

11 August 2017

Kazuhiko Tsuruya

7

1 reference

11 August 2017

Hideaki Yoshida

8

1 reference

11 August 2017

Tsuyoshi Watanabe

10

1 reference

11 August 2017

14 December 2011

1 reference

Clinical and experimental nephrology

11 August 2017

1 reference

11 August 2017

16

1 reference

11 August 2017

2

1 reference

11 August 2017

279-291

1 reference

Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3328680

A predictive model for progression of chronic kidney disease to kidney failure

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3328680

Renal protection with angiotensin receptor blockers: where do we stand.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3328680

New diagnostic criteria for diabetes in Japan

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3328680

Population based screening for chronic kidney disease: cost effectiveness study

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3328680

Challenging chronic kidney disease: experience from chronic kidney disease prevention programs in Shanghai, Japan, Taiwan and Australia

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3328680

Epidemiology and natural history of atherosclerotic renovascular disease

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3328680

The Japanese national health screening and intervention program aimed at preventing worsening of the metabolic syndrome

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3328680

Screening for chronic kidney disease: where does Europe go?

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3328680

Chronic kidney disease perspectives in Japan and the importance of urinalysis screening

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3328680

Kidney disease screening program in Japan: history, outcome, and perspectives

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3328680

The organization and financing of end-stage renal disease treatment in Japan.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3328680

A health economic evaluation of aspirin in the primary prevention of cardiovascular disease in Japan

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3328680

Chronic kidney disease: the global challenge

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3328680

Use of cost-effectiveness analysis in health-care resource allocation decision-making: how are cost-effectiveness thresholds expected to emerge?

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3328680

Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3328680

Demographic study of first-ever stroke and acute myocardial infarction in Okinawa, Japan

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3328680

Comprehensive public health strategies for preventing the development, progression, and complications of CKD: report of an expert panel convened by the Centers for Disease Control and Prevention

11 July 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-011-0567-1

Who should be targeted for CKD screening? Impact of diabetes, hypertension, and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-011-0567-1

Screening for proteinuria in US adults: a cost-effectiveness analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-011-0567-1

Risk of developing end-stage renal disease in a cohort of mass screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-011-0567-1

Incidence and long-term prognosis of initial stroke and acute myocardial infarction in Okinawa, Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-011-0567-1

Evidence for high incidence of end-stage renal disease in patients after stroke and acute myocardial infarction at age 60 or younger

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-011-0567-1

Measurement of health-related quality of life in patients with chronic kidney disease in Japan with EuroQol (EQ-5D).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-011-0567-1

Cost-utility analysis of antihypertensive combination therapy in Japan by a Monte Carlo simulation model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-011-0567-1

Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-011-0567-1

Tonsillectomy and steroid pulse therapy significantly impact on clinical remission in patients with IgA nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-011-0567-1

Effect of a multifactorial intervention on mortality in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-011-0567-1

Design and methods of a strategic outcome study for chronic kidney disease: Frontier of Renal Outcome Modifications in Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-011-0567-1

International survey on willingness-to-pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness?

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3328680

Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy

24 September 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-011-0567-1

Validity of the JNC VI recommendations for the management of hypertension in a general population of Japanese elderly: the Hisayama study

21 January 2018

1 reference

12 December 2020

1 reference

12 December 2020

Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia)

1 reference

12 December 2020

An overview of regular dialysis treatment in Japan as of 31 December 2003

1 reference

12 December 2020

[Stroke register in Akita: incidence and the burden of diseases]

1 reference

12 December 2020

Health technology assessment in Canada: 20 years strong?

1 reference

12 December 2020

Therapeutic advantage of angiotensin-converting enzyme inhibitors in patients with proteinuric chronic kidney disease

1 reference

12 December 2020

Screening for chronic kidney disease

1 reference

12 December 2020

The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report

1 reference

12 December 2020

10.1007/S10157-011-0567-1

Identifiers

DOI

1 reference

release_wap6daczgrhpdhb4l47toog5iq

11 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wap6daczgrhpdhb4l47toog5iq

24 November 2022

mapped directly with Wikidata item

1 reference

11 August 2017

PubMed publication ID

22167460

1 reference